Faber Frank W M, Mastboom Monique J L, van Vliet-Koppert Sabine T, Bouman Ilse C E, van Kampen Paulien M
Department of Orthopaedic Surgery, Bergman Clinics, Rijswijk, Netherlands.
Department of Orthopaedic Surgery, LUMC, Leiden, Netherlands.
Adv Orthop. 2018 Aug 1;2018:2735634. doi: 10.1155/2018/2735634. eCollection 2018.
While ankle arthrodesis was traditionally the gold standard method of treatment for disabling end-stage ankle arthritis, total ankle replacement (TAR) has been an acceptable alternative. The satisfaction rate of patients with TAR however differs. The purpose of our study is to investigate whether implant survival and results with special emphasis on the satisfaction rate of patients treated with a TAR implanted by a single surgeon were comparable to the literature. This was a retrospective cohort study in a teaching hospital. Data was collected from 52 patients who received a total ankle replacement (TAR) between 05/2002 and 06/2014. The mean follow-up time was 4.2 years (95% CI 3.3 - 5.0). Results showed a high satisfaction rate of 94% and 94% survival of the TAR after 5 years. We conclude that TAR with the Salto prosthesis is, in our hands, a reliable solution for end-stage ankle arthritis, with results comparable to the literature.
虽然传统上踝关节融合术是治疗致残性终末期踝关节炎的金标准方法，但全踝关节置换术（TAR）已成为一种可接受的替代方法。然而，接受TAR治疗的患者的满意度有所不同。我们研究的目的是调查由单一外科医生植入TAR治疗的患者的植入物存活率和结果，特别强调患者的满意度是否与文献相当。这是一项在教学医院进行的回顾性队列研究。收集了2002年5月至2014年6月期间接受全踝关节置换术（TAR）的52例患者的数据。平均随访时间为4.2年（95%可信区间3.3 - 5.0）。结果显示，5年后TAR的满意度高达94%，存活率为94%。我们得出结论，在我们手中，使用Salto假体的TAR是终末期踝关节炎的可靠解决方案，其结果与文献相当。
